Latka logo

2021 Revenue

$544.8K

Customers

8K

Avg ACV

$68

Team

21

Founded

1999

Curaspan Revenue (2021)

Curaspan generated $544.8K in revenue in 2021.

Provider of patient-transition networks for hospitals, post-acute providers, payers and suppliers to optimize patient care. The company offers software-as-a-service (SaaS) applications, which assist users with real-time, predictive decision-making data that enables all participants to continuously monitor care, improve communication and ensure compliance. It provides services under the brand names Curaspan Platform, DischargeCentral, ReferralCentral, RideCentral and ReviewCentral.

Last updated

Curaspan Revenue

In 2021, Curaspan's revenue reached $544.8K.

Curaspan Revenue GrowthReported revenue / ARR over time$0$125K$250K$375K$500K$625K199920012003200520072009201120132015201720192021$0$544.8KSource: GetLatka.com
YearMilestoneSource
2021Curaspan Hit $544.8k revenue in April 2021Not recorded
1999Launched with $0 revenue

Founder / CEO

Customers

Curaspan serves 8K customers.

Curaspan Employees & Team Size

Curaspan employs approximately 21 people as of 2026. It serves 8K customers that rely on its solutions.

Curaspan Team GrowthReported headcount over time0510152025199920012003200520072009201120132015201720192021002121Source: GetLatka.com
YearMilestoneSource
2021Reached 21 employees (April 2021)Not recorded

Frequently Asked Questions about Curaspan

Who owns Curaspan?

Curaspan is owned by NaviHealth, which acquired it.

What is Curaspan's revenue?

As of 2021, Curaspan generated $544.8K in revenue.

Who founded Curaspan?

Curaspan was founded by Thomas Ferry.

When was Curaspan founded?

Curaspan was founded in 1999.

How many employees does Curaspan have?

As of 2021, Curaspan had 21 employees.

Compare Curaspan to the industry

Curaspan operates across multiple industries. Browse revenue, funding, and growth data for Curaspan in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile